Loomis Sayles & CO L P Crispr Therapeutics Ag Transaction History

Loomis Sayles & CO L P

$69.2 Billion
Q1 2025

A detailed history of Loomis Sayles & CO L P transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Loomis Sayles & CO L P holds 909,792 shares of CRSP stock, worth $33 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

909,792

Previous 910,965 0.13%

Holding current value

$33 Million

Previous $35.9 Million 13.65%

% of portfolio

0.04%

Previous 0.05%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$34.03 - $53.02 $39,917 - $62,192	-1,173 Reduced 0.13%	909,792 $31 Million
Q4 2024 Feb 12, 2025	SELL	$38.65 - $55.15 $1.33 Million - $1.89 Million	-34,302 Reduced 3.63%	910,965 $35.9 Million
Q3 2024 Nov 13, 2024	SELL	$44.62 - $62.75 $2.72 Million - $3.82 Million	-60,946 Reduced 6.06%	945,267 $44.4 Million
Q2 2024 Aug 13, 2024	SELL	$51.17 - $68.18 $973,765 - $1.3 Million	-19,030 Reduced 1.86%	1,006,213 $54.3 Million
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $2.55 Million - $3.75 Million	-42,108 Reduced 3.95%	1,025,243 $69.9 Million
Q4 2023 Feb 13, 2024	SELL	$38.62 - $72.18 $1.12 Million - $2.09 Million	-29,003 Reduced 2.65%	1,067,351 $66.8 Million
Q3 2023 Nov 09, 2023	SELL	$45.39 - $59.0 $2.34 Million - $3.04 Million	-51,575 Reduced 4.49%	1,096,354 $49.8 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $386,057 - $601,865	-8,881 Reduced 0.77%	1,147,929 $64.4 Million
Q1 2023 May 11, 2023	SELL	$41.0 - $56.12 $1.29 Million - $1.77 Million	-31,511 Reduced 2.65%	1,156,810 $52.3 Million
Q4 2022 Feb 10, 2023	SELL	$39.19 - $65.67 $2.23 Million - $3.74 Million	-56,878 Reduced 4.57%	1,188,321 $48.3 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $9.23 Million - $12.7 Million	-151,059 Reduced 10.82%	1,245,199 $81.4 Million
Q2 2022 Aug 05, 2022	BUY	$43.23 - $73.83 $4.55 Million - $7.78 Million	105,353 Added 8.16%	1,396,258 $84.9 Million
Q1 2022 May 13, 2022	SELL	$53.19 - $79.24 $1.34 Million - $2 Million	-25,218 Reduced 1.92%	1,290,905 $81 Million
Q4 2021 Feb 14, 2022	BUY	$70.09 - $111.29 $27.3 Million - $43.4 Million	390,209 Added 42.14%	1,316,123 $99.7 Million
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $1.9 Million - $2.7 Million	17,262 Added 1.9%	925,914 $104 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $91.6 Million - $147 Million	908,652 New	908,652 $147 Million

Others Institutions Holding CRSP

# of Institutions

479

Shares Held

64.2M

Call Options Held

2.15M

Put Options Held

1.92M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $2.83B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Crispr Therapeutics Ag Transaction History